U.S. FDA Acknowledges Receipt of Shire's New Drug Application for SHP465 for ADHD - Yahoo Finance

Submitted by Anonymous (not verified) on Thu, 01/19/2017 - 12:18

U.S. FDA Acknowledges Receipt of Shire's New Drug Application for SHP465 for ADHDYahoo FinanceShire plc (LSE: SHP, NASDAQ: SHPG) announced that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of the Class 2 resubmission of a New Drug Application (NDA) for SHP465, a long-acting, triple-bead, mixed amphetamine salts ...and more »